Generic

January 31, 2019

Mylan makes for a piece of the shrinking Advair pie

October 31, 2018

Samsung joins Soliris biosimilar quest

September 07, 2018

Civica Rx goes where generics companies fear to tread

A non-profit partnership of 500 hospitals wants to deliver its first generic drugs in 2019, lowering prices and stabilising supplies.

August 17, 2018

With Epipen Teva investors have something to celebrate at last

May 15, 2018

Pfenex readies to swim upstream with Forteo copycat

May 03, 2018

Biosimilar knockbacks expose increasing big pharma focus

April 17, 2018

Private equity cleans up Sanofi’s failed generics foray

February 20, 2018

Interview – Rani’s pill injector promises much, but is still preclinical

January 24, 2018

Novartis investors put faith in new chief